SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Jun Zhao, Yi‐Long Wu, Dingzhi Huang et al.|Journal for ImmunoTherapy of Cancer|2023

Cited by 21